摘要
目的 研究产前用地塞米松治疗对早产儿呼吸窘迫综合征 (RDS)发生率的影响。 方法 对 16 4例早产儿按产前地塞米松治疗组及非治疗组进行回顾性分析。 结果 产前使用地塞米松治疗可使早产儿 RDS发生率显著降低 ,主要表现在极低出生体重儿中 ;产前地塞米松治疗对其它肺部疾病发生率的降低无显著意义。 结论 产前地塞米松治疗可促进胎肺的成熟并改善其换气功能 ,对极低出生体重儿尤为重要 。
Objective To study retrospectively the effect of prenatal therapy with dexamethasone on the incidence of premature respiratory distress syndrome(RDS). Methods One hundred and sixty four premature babies were divided into two groups: therapeutic and control group. The incidence of RDS and pulmonary diseases was analyzed. Results Prenatal therapy with dexamethasone reduced the incidence of RDS significantly in premature infants, especially in very low birth weight infants. The incidence of other pulmonary diseases are similar between the two groups. Conclusion Prenatal dexamethasone therapy facilitates the lung maturity and improves pulmonary function of premature infants, especially in very low birth weight infants.
出处
《中华围产医学杂志》
CAS
2000年第1期24-25,共2页
Chinese Journal of Perinatal Medicine